Skip to content
Markets News
AI & Tech1 min read

Isomorphic Labs Raises $5 Billion to Fund AI Drug Discovery

Makkler Newsroom
November 17, 2026 · Based on reporting by CNBC
Photo: Esculab / Wikimedia Commons · CC0

The Series C was co-led by Greenoaks and Sequoia Capital, with Alphabet among the investors, the startup said.

Key takeaways

  • Isomorphic Labs raised $5 billion in a Series C round.
  • Greenoaks and Sequoia Capital co-led the round, which included investment from Alphabet.

Isomorphic Labs has raised $5 billion in a Series C round to support its AI-driven drug discovery work, the startup said Tuesday.

Greenoaks and Sequoia Capital co-led the financing, alongside Andreessen Horowitz. Alphabet, Google’s parent company, also invested.

The company is developing AI tools to design medicines and plans to advance its first therapeutic programs toward clinical trials. Drug discovery startups raised a record $23.2 billion in 2026, according to Dealroom.

Topics
GOOGLIsomorphic Labs
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.